drugset
drugset / Trial / NCT04683185

A Study to Assess the Safety and Tolerability of E6742 in Japanese Healthy Adult Participants

NCT04683185 ↗

Phase 1 Completed 24 enrolled Eisai Inc.
RandomizedParallel-groupDouble-blindOther

Summary

The primary purpose of the study is to evaluate the safety, tolerability and pharmacokinetics (PK) of multiple ascending oral doses of E6742 in Japanese healthy adult participants.

Timeline

Start
2020-12-28
Primary completion
2021-06-21
Completion
2021-06-21

Drugs

EvaluationDrugModalityDoseRoute
Subject E6742 Unknown 100 mg Oral
Subject E6742 Unknown 200 mg Oral
Subject E6742 Unknown 400 mg Oral

Indications

No indication recorded.